Objectives: to evaluate the frequency of thyroid disorders in primary
Sjogren's syndrome. Patients and methods: 121 consecutive patients mee
ting Vitali's criteria for primary Sjogren's syndrome and 74 with rheu
matoid arthritis underwent thyroid hormone assays, tests for antimicro
somal and antithyroglobulin antibodies, tests for antinuclear antibodi
es and antibodies to extractable nuclear antigens. Antimicrosomal and
antithyroglobulin antibodies were also assayed in 404 controls. Result
s: frequencies were calculated separately in males and females, and da
ta in females were subjected to statistical analysis. As compared with
controls, Sjogren's syndrome patients were more likely to have antimi
crosomal antibodies (9% versus 17.6%, P<0.05) and both Sjogren's syndr
ome and rheumatoid arthritis patients were more likely to have antithy
roglobulin antibodies (1% versus 13.4% and 10.9%, respectively, P<0.00
01). Hypothyroidism was more common among Sjogren's syndrome patients
(13.4%) than rheumatoid arthritis patients (3.1%) (P<0.05). Sjogren's
syndrome patients with thyroid disorders were less likely to have anti
nuclear antibodies, rheumatoid factors or a Chisholm's stage 3 or 4 li
p biopsy. Conclusions: our data confirm that thyroid disorders are mor
e common in primary Sjogren's syndrome than in rheumatoid arthritis an
d controls. Production of autoantibodies and severe histologic lesions
were less common in Sjogren's syndrome patients with than without thy
roid disorders.